Q3 2025 Holdings
Filed 2025-11-14 | 43 holdings | $439.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $126.1M | 3,204,184 | 28.7% |
| CG Oncology Inc(CGON) | COM | 156944100 | $64.5M | 1,600,899 | 14.7% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $18.2M | 190,600 | 4.1% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $16.0M | 164,300 | 3.7% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $12.7M | 660,424 | 2.9% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $11.6M | 257,600 | 2.6% |
| Natera Inc(NTRA) | COM | 632307104 | $11.3M | 70,400 | 2.6% |
| Danaher Corporation(DHR) | COM | 235851102 | $10.8M | 54,700 | 2.5% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $10.3M | 510,000 | 2.3% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $10.3M | 2,994,033 | 2.3% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $9.7M | 1,127,186 | 2.2% |
| Pfizer Inc(PFE) | COM | 717081103 | $9.3M | 366,400 | 2.1% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $9.2M | 18,900 | 2.1% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $8.7M | 8,981,855 | 2.0% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $7.6M | 248,100 | 1.7% |
| Metsera Inc | COM | 59267L107 | $7.4M | 140,500 | 1.7% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $6.1M | 17,800 | 1.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $6.0M | 698,363 | 1.4% |
| Cencora Inc(COR) | COM | 03073E105 | $5.9M | 19,000 | 1.4% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $5.3M | 41,900 | 1.2% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $5.0M | 26,800 | 1.1% |
| The Cigna Group(CI) | COM | 125523100 | $4.8M | 16,600 | 1.1% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $4.6M | 19,800 | 1.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $4.5M | 5,800 | 1.0% |
| Carlsmed Inc(CARL) | COM | 14280C105 | $4.3M | 321,912 | 1.0% |
| Kenvue Inc(KVUE) | COM | 49177J102 | $4.3M | 265,200 | 1.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $4.1M | 4,699,411 | 0.9% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $4.0M | 214,400 | 0.9% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $4.0M | 73,600 | 0.9% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $3.6M | 306,000 | 0.8% |
| Repligen Corp(RGEN) | COM | 759916109 | $3.1M | 23,300 | 0.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $3.1M | 144,000 | 0.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $2.9M | 14,500 | 0.7% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $2.9M | 140,300 | 0.7% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $2.7M | 112,000 | 0.6% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $2.6M | 3,350,528 | 0.6% |
| Healthequity Inc(HQY) | COM | 42226A107 | $2.4M | 25,300 | 0.5% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $2.2M | 297,500 | 0.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $2.1M | 53,400 | 0.5% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $1.9M | 40,500 | 0.4% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.7M | 11,600 | 0.4% |
| Karyopharm Therapeutics Inc(KPTI) | COM NEW | 48576U205 | $880.1K | 134,566 | 0.2% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $636.3K | 90,900 | 0.1% |